Title of article :
Radiothérapie postopératoire dans le cancer bronchique non à petites cellules. ہ propos dʹune série de 374 cas
Author/Authors :
Baillet، نويسنده , , F and Manoux، نويسنده , , D and Lange، نويسنده , , J and Homasson، نويسنده , , J.P. and Simon، نويسنده , , J.M. and Diana، نويسنده , , C and Dessard-Diana، نويسنده , , B and Ronchin، نويسنده , , P and Pierga، نويسنده , , J.Y. and Housset، نويسنده , , M and Mazeron، نويسنده , , J.J. and Rozec، نويسنده , , C، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1997
Abstract :
SummaryPurpose
l randomized trials have led us to address the usefulness of post-surgical external beam therapy (EBT) in non-oat cell bronchial carcinoma. Results that were obtained in a group of 374 patients submitted between 1977 and 1994 to identical therapy-the follow-up being done by the same team — and results of six randomized trials are analyzed.
ts and methods
mor stages were the following: T1, 13%; T2, 56%; T3, 29%; and T4, 2%; N0, 31 %; N1, 34%; and N2, 35%. There were 85% histologically complete resections. EBT was administered according to either the classical irradiation scheme (C) or as an ‘equivalent hypofractionated dose’ (H) in the case of complete resection. When resection was not complete, 60 to 65 Gy were administered according to a C or an H irradiation scheme. The irradiation scheme was C in 73% of the cases and H in 27%. The EBT technique has been chosen to ensure maximum lung sparing. Following a 45 Gy-irradiation with anteroposterior beams, orthogonal or, when necessary, oblique beams were used. Non homogeneity of the lungs was taken into account in establishing the treatment planning. The treatment file was collectively checked by the medical staff in 75% of the cases. EBT was indicated for N + (N1+N2), T3 and noncomplete resections.
s
erall survival was 42% at 5 years and 27% at 10 years. The 5-year survival was 52% for stage I cancer (T1 NO-T2N0), 60% for stage II cancer (T1 N1 — T2N1), 31% for stage IIIa cancer (T3N0, T1-3N2), 45% for complete resection and 30% when resection was not complete.
sion
ing the benefits of post-surgical radiotherapy, the analysis of the six randomized trials does not allow any conclusion. This might be due to either the insufficient number of cases, a follow-up time not long enough, incorrect radiotherapy, or insufficient available data. Comparison of the results pertainingto the six trials with those of our series shows an advantage for the current series, indicating that survival is likely to be improved if EBT is correctly done with regard to the dose, volume and technique used.
Keywords :
radiation therapy , Cancer bronchique non à petites cellules , Chirurgie , Radiothérapie , Non-small cell lung cancer , surgery
Journal title :
Cancer Radiotherapie
Journal title :
Cancer Radiotherapie